News for iCo Therapeutics Inc. (ICO.V)

Visiongain has published a new report entitled Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033: Forecasts by Therapeutic Application...

Read iCo Therapeutics (OTCMKTS:ICOTF) Share Price Crosses Below 200 Day Moving Average of $0.50 at ETF Daily News

Read iCo Therapeutics (OTCMKTS:ICOTF) Share Price Crosses Below Two Hundred Day Moving Average of $0.61 at ETF Daily News

Read iCo Therapeutics (OTCMKTS:ICOTF) Shares Down 46.9% at ETF Daily News

Satellos Bioscience Inc. , a regenerative medicine company focused on the treatment of degenerative muscle disorders, announced today core findings from additional preclinical drug development... | September 13, 2021

Satellos Bioscience Inc. , formerly iCo Therapeutics Inc. , today filed financial results and MD&A reports for the second quarter which ended on June 30, 2021, on SEDAR. Amounts, unless specified... | August 30, 2021

VANCOUVER, BC, Aug. 17, 2021 /CNW/ - Trading resumes in: Company: atellos Bioscience Inc FORMERLY:  iCo Therapeutics Inc. TSX-Venture Symbol: MSCL

VANCOUVER, BC, Aug. 17, 2021 /CNW/ - Trading resumes in: Company: atellos Bioscience Inc FORMERLY:  iCo Therapeutics Inc.TSX-Venture Symbol: MSCL ...

VANCOUVER, BC, Aug. 17, 2021 /CNW/ - Trading resumes in: Company: atellos Bioscience Inc FORMERLY:  iCo Therapeutics Inc.TSX-Venture Symbol: MSCL ...

VANCOUVER, BC, Aug. 17, 2021 /CNW/ - Trading resumes in: Company: Satellos Bioscience Inc FORMERLY:  iCo Therapeutics Inc. TSX-Venture Symbol: MSCL

VANCOUVER, BC, Aug. 16, 2021 /CNW/ - TSX VENTURE COMPANIESBUILDDIRECT.COM TECHNOLOGIES INC. ('BILD')[formerly BuildDirect.com Technologies Inc. ('...

VANCOUVER, BC, Feb. 26, 2021 /CNW/ -TSX VENTURE COMPANIESKALYTERA THERAPEUTICS INC. ('KLY') ('KLY.WT.B') ('KLY.WT.A')BULLETIN TYPE:  CORRECTION, R...

VANCOUVER, BC, Feb. 25, 2021 /CNW/ -TSX VENTURE COMPANIESMINEWORX TECHNOLOGIES LTD. ('MWX.RT')BULLETIN TYPE:  Rights Expiry-DelistBULLETIN DATE:  ...